Am I too late to buy MRK?

Merck & Co., Inc. (MRK): Yes, too late. We wouldn't buy it here.

Verdict as of .

Our model puts the odds of MRK being higher in three months at 34% (worse than a coin flip), and its three-month estimate is $148.59, 2.0% below today's $151.64. Buying now means paying more than we think it will be worth, so we wouldn't start a position at this price: a missed trade costs nothing, this one can.

Where we'd be wrong: We're wrong if MRK closes above $168.62 within three months, the top of our 90% forecast band. Above that our model under-called the move: our call failed, and we withdraw it.

The prices behind this verdict

Why: the risk checks behind the call

Related pages:

Educational research only — not investment advice.